Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

This article originally appeared here.
Share this content:
Mobile Stroke Treatment Unit Feasible for Acute Stroke Care
Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

TUESDAY, Dec. 8, 2015 (HealthDay News) -- A mobile stroke treatment unit (MSTU) is feasible for providing acute stroke treatment, according to a study published online Dec. 7 in JAMA Neurology.

In a prospective observational cohort study, Ahmed Itrat, M.D., from the Cleveland Clinic, and colleagues examined whether telemedicine is reliable and remote physician presence is adequate for acute stroke treatment using an MSTU. Participants were 100 residents of Cleveland with an acute onset of stroke-like symptoms who were evaluated by the MSTU. The patients were evaluated by a vascular neurologist via telemedicine; a neuroradiologist remotely assessed images obtained by mobile computed tomography.

Ninety-nine of the patients were successfully assessed, with a median duration of assessment of 20 minutes. The researchers found that there was one connection failure due to crew error; the patient was transported to the emergency department. Six telemedicine disconnections occurred, none of which lasted for more than 60 seconds or impacted clinical care. The times from door to CT completion and from door to intravenous thrombolysis were 13 and 32 minutes, respectively, in the MSTU group, which were significantly shorter than in the control group (18 and 58 minutes, respectively). There was no between-group difference noted in times to CT interpretation.

"An MSTU using telemedicine is feasible, with a low rate of technical failure, and may provide an avenue for reducing the high cost of such systems," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »